Leonteq Securities’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
Other funds holding FATE
Leonteq Securities's FATE Position: Q3 2026 in Review
Leonteq Securities held its Fate Therapeutics (FATE) position steady in Q3 2026 at 19 shares worth $45. The position accounts for ﹤0.01% of the portfolio, ranked #1273.
Leonteq Securities first reported a position in FATE in Q4 2020 and has held it in 21 quarters since. The position peaked at $362K in Q4 2020. 142 funds tracked by Wall St. Rank hold FATE as of Q3 2026.
- Leonteq Securities held 19 shares of Fate Therapeutics worth $45 as of Q3 2026.
- Leonteq Securities left its Fate Therapeutics share count unchanged in Q3 2026.
- Fate Therapeutics made up ﹤0.01% of Leonteq Securities's portfolio in Q3 2026, its #1273 holding.
- Leonteq Securities first reported a position in Fate Therapeutics in Q4 2020 and has held it in 21 quarters since.
- Leonteq Securities's Fate Therapeutics position peaked at $362K in Q4 2020.
- 142 funds tracked by Wall St. Rank held Fate Therapeutics as of Q3 2026.
Based on Leonteq Securities's 13F filing for Q3 2026, filed 29 Oct 2026.